About Kevin Hill, MD
Dr. Kevin Hill is Director of Addiction Psychiatry at Beth Israel Deaconess Medical Center (BIDMC) an Associate Professor of Psychiatry at Harvard Medical School. Dr. Hill graduated from Jefferson Medical College in Philadelphia, PA and then completed the Harvard Longwood Psychiatry Residency Training Program. He earned a Master’s in Health Science at the Robert Wood Johnson Clinical Scholars Program at the Yale School of Medicine. He is board-certified in General Psychiatry and Addiction Psychiatry. After eight years on the staff at McLean Hospital in Belmont, MA, he came to BIDMC to start the Division of Addiction Psychiatry in 2017.
He most commonly treats patients who have problems with alcohol, cannabis, or opioids and has been named one of Boston Magazine’s Top Doctors since 2019. He teaches medical students and physicians how to treat patients with addictions. He treats professional athletes from the National Football League (NFL), the National Basketball Association, and the Boston Red Sox, as well as airline pilots. He consults to the NFL and is the Co-Chair of the NFL/NFL Players’ Association Pain Management Committee. The author of Marijuana: The Unbiased Truth about the World’s Most Popular Weed (Hazelden 2015) and co-author of Medical Cannabis: An Evidence-Based Guide (Wolters-Kluwer 2020), Dr. Hill’s research interests include the development of medications to treat cannabis use disorder as well as cannabis policy, and he has published widely on these topics in such journals as JAMA, JAMA Internal Medicine, and Lancet Psychiatry. In 2018, he was awarded a grant to summarize the research on the therapeutic use of cannabis and he presented his findings to the World Health Organization’s Expert Committee on Drug Dependence in Geneva, Switzerland. He serves on the editorial boards of Cannabis and Cannabinoid Research and the American Journal on Addictions.
Dr. Hill has become an internationally-recognized speaker on addiction topics due to his ability to connect with audiences and make complex concepts understandable. He gives balanced, evidence-based talks on cannabis, opioids, and alcohol to a wide variety of audiences. Dr. Hill, who is from Rochester, NY, lives in Newton, MA with his wife Debbie and their daughters, Hannah and Sophie. Dr. Hill enjoys following sports, reading, and running.
Select Publications
-
Marijuana: The Unbiased Truth about the World's Most Popular Weed now available on Amazon.
-
April 2020 - Journal of the Neurological Sciences, Clinical uses of cannabis and cannabinoids in the United States.
-
February 2020 – JAMA, Medical cannabis.
-
February 2020 - Journal of Palliative Medicine, Managing opioid use disorder in the setting of a terminal disease: Opportunities and challenges.
-
November 2019 - The American Journal on Addictions, Review: Non-invasive brain stimulation in behavioral addictions: insights from direct comparisons with substance use disorders.
-
November 2019 – The Journal of Emergency Medicine, How emergency physicians approach refusal of observation after naloxone resuscitation.
-
September 2019 - Cannabis and Cannabinoid Research, Priority considerations for medicinal cannabis-related research.
-
August 2019, JAMA, Medical use of cannabis in 2019.
-
April 2019 - Focus: Journal of the Life Long Learning in Psychiatry, Cannabis and the current state of treatment for cannabis use disorder.
-
February 2019 - Lancet Psychiatry, Therapeutic cannabis use in 2018: where do we stand?
-
September 2018 - Current Addiction Reports, Cannabis and mood disorders.
-
July 2018 – Canadian Journal of Psychiatry, Cannabis legalization and psychiatric disorders: caveat “hemp-tor”.
-
May 2018 - JAMA Internal Medicine, The role of cannabis legalization in the opioid crisis.
-
December 2017 – The American Journal on Addictions, Nabilone pharmacotherapy for cannabis dependence: A randomized, controlled pilot study.
-
November 2017 - Polish Archives of Internal Medicine, Medical cannabis for the treatment of chronic pain and other disorders: misconceptions and facts.
-
May 2017 – Cannabis and Cannabinoid Research, Cannabis and pain: A clinical review.
-
March 2017 – JAMA, Cannabis use and risk for substance use disorders and mood or anxiety disorders.
-
September 2016 – Lancet Psychiatry, Recreational cannabis legalisation: details will determine mental health effects.
-
June 2016 – JAMA, Minimal physical health risk associated with long-term cannabis use—but buyer beware.
-
February 2016 – Evidence-Based Medicine, Low to moderate quality evidence demonstrates the potential benefits and adverse events of cannabinoids for certain medical indications.
-
July-August 2015 – Journal of Opioid Management, Sleep-disordered breathing in patients with opioid use disorders in long-term maintenance on buprenorphine-naloxone: A case series.
-
June 2015 – JAMA, Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: A clinical review.
-
September 2014 – Journal of Psychiatric Practice, Medical marijuana: more questions than answers.
-
November 2013 – American Family Physician, After detoxification: levels of treatment for alcohol dependence.
-
September 2013 – Drug and Alcohol Dependence, Association of cannabis use with opioid outcomes among opioid-dependent youth.
-
May-June 2013 – The American Journal on Addictions, Cognitive behavioral therapy and the nicotine transdermal patch for dual nicotine and cannabis dependence: A pilot study.
-
December 2012 – Current Psychiatry Reports, Bipolar disorder and alcohol use disorder: a review.
-
October 2012 – The Journal of Family Practice, Diagnosing and treating opioid dependence.